BHRT Financials 07/16/2014 15:18:15 Bioheart, Inc
Post# of 235
Bioheart, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 96 61 17 46
Cost of Revenue 31 1 1 20
Gross Profit 65 60 17 27
Operating Expenses
Research and Development 627 402 465 1,467
Sales, General and Admin. 2,268 2,178 2,127 1,769
Non-Recurring Items - - 59 -
Other 2 15 32 57
Operating Income (2,832) (2,535) (2,666) (3,266)
Income From Continuing Operations
Add'l Income/Expense Items 1,126 138 (18) 246
Earnings Before Interest and Tax (1,705) (2,397) (2,684) (3,020)
Interest Expense 1,438 1,620 2,013 2,139
Earnings Before Tax (3,143) (4,016) (4,697) (5,159)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,120) (4,016) (4,697) (5,159)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,143) (4,016) (4,697) (5,159)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,143) (4,016) (4,697) (5,159)